Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.56 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.56 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.56 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.56 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.55 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1224829 | 0.86 | MEN1 (0.73) | NPC1MEN1KMT2APOLBMAPK1 | |
| SCHEMBL30620465 | 0.86 | MEN1 (0.73) | NPC1MEN1KMT2APOLBMAPK1 | |
| SCHEMBL74720 | 0.85 | MEN1 (0.71) | NPC1MEN1KMT2APOLBMAPK1 | |
| SCHEMBL29992449 | 0.85 | MEN1 (0.71) | NPC1MEN1KMT2APOLBMAPK1 | |
| SCHEMBL31504069 | 0.85 | NPC1 (0.62) | NPC1MEN1KMT2APOLBMAPK1 | |
| Hydrochloric Acid SCHEMBL27528155 | 0.83 | MEN1 (0.69) | NPC1MEN1KMT2APOLBMAPK1 | |
| Ammonia Solution, Strong SCHEMBL28589598 | 0.83 | MEN1 (0.69) | NPC1MEN1KMT2APOLBMAPK1 | |
| Biphenyl SCHEMBL27962650 | 0.83 | NPC1 (0.64) | NPC1MEN1KMT2APOLBMAPK1 | |
| SCHEMBL5850255 | 0.82 | NPC1 (0.79) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL8868277 | 0.82 | MEN1 (0.58) | MEN1KMT2APOLBMAPK1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112144074-B | Method for preparing dibit bromoindole by using electrochemical microchannel device | 南京先进生物材料与过程装备研究院有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-112144074-B | Method for preparing dibit bromoindole by using electrochemical microchannel device | 南京先进生物材料与过程装备研究院有限公司 | 2021-12-03 | — | — | CN | disclosed |
| CN-112144074-A | Method for preparing dibit bromoindole by using electrochemical microchannel device | 南京先进生物材料与过程装备研究院有限公司 | 2020-12-29 | — | — | CN | disclosed |
| US-20030203959-A1 | Novel modulators of potassium channels | 4SC AG (DE) | 2003-10-30 | — | — | US | disclosed |
| EP-0674620-A1 | TRYPTAMINE ANALOGUES AS 5-HT 1?-LIKE AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1995-10-04 | — | — | EP | disclosed |
| WO-1994014771-A1 | TRYPTAMINE ANALOGUES AS 5-HT1-LIKE AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203959-A1 | Novel modulators of potassium channels | HCN3, KCNN3, KCNN1 | NPC1 487/4885MEN1 4525/4885KMT2A 1874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.